Open, self-updating tools built from official data to support cancer research, clinical practice and policy — free for researchers, clinicians and policymakers to use. Three are live today; one is on the way.
New oncology & haematology drug approvals from the FDA and EMA, 2016 to today. Filter by tumour stream or medicine, and compare FDA vs EMA approvals side by side. Official open data, refreshed weekly.
An interactive world map of per-patient cancer costs — direct, out-of-pocket and total — drawn from published country studies. A working evidence tool, still under validation and testing.
New and updated oncology trials from ClinicalTrials.gov — by phase, sponsor, status and geography, refreshed automatically. The same open-data approach as the approvals tracker.
Projecting the future economic burden of cancer on society under different demographic, incidence and intervention scenarios — to inform long-term planning and investment.
Every tool is built from official open data, is transparent about its sources, and updates itself — no scraping, no black boxes. Want to help shape one, or suggest a tool we should build? We'd like to hear from you.
Get in touch